Use of collagenase to facilitate guide wire crossing in total arterial occlusions

a technology of total arterial occlusion and collagenase, which is applied in the direction of drug compositions, peptide/protein ingredients, extracellular fluid disorder, etc., can solve the problems of reduced procedural success rate compared, high restnosis rate, and purely mechanical design of stiffer and more powerful guide wires to try and push through fibrotic total occlusions only has limited

Inactive Publication Date: 2005-03-10
STRAUSS BRADLEY H
View PDF8 Cites 13 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The use of a collagenase containing formulation has been identified for degrading collagen within an occlusive atherosclerotic plaque in a chronically occluded animal tube or cavity. More particularly, a collagenase containing formulation is used as an infusion preparation for administration and retention of a therapeutic dosage of collagenase adjacent to or into the atherosclerotic plaque during a formulation exposure waiting period.
A medical-related apparatus is provided for degrading collagen within an occlusive atherosclerotic plaque in a chronically occluded animal tube or cavity comprising a me

Problems solved by technology

However, since PCI have severe limitations in this patient subset, clinicians frequently decide to refer these patients for bypass surgery or persist with (often ineffective) medical therapy.
The main limitations of PCI for CTO are the decreased procedural success rates compared to stenotic (but not totally occluded) arteries, and a high restenosis rate.
Thus a purely mechanical approach of designing stiffer and more powerful guide wires to try and push through fibrotic total occlusions has only limited efficacy.
Although thrombolytic therapy is effective in acute coronary occlusions, only a small number of native artery chronic occlusions have been treated with prolonged thrombolytic infusions with limited results and this strategy has largely been abandoned.
Consequently, significant angina pectoris represents the most common cause of attempted PCI in the setting of CTO.
The situation of inadequate blood supply to viable myocardium (termed “hibernating myocardium”) is also a major cause of potentially reversible myocardial dysfunction leading to heart failure.
Moreover, there is accumulating data that CTO portend a poorer prognosis.
Release of various enzymes (trysin or papain alone or in combination with collagenase) frequently resulted in not only dissolution of the plaques but also caused extensive damage to the media of the artery.
Moreover, none of these studies address the unique clinical situation of a chronically occluded artery in which a long segment of artery is completely occluded and will not permit the passage of guide wires which are an absolute requirement for performing balloon angioplasty and stenting.
Experimental studies of chronically occ

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of collagenase to facilitate guide wire crossing in total arterial occlusions
  • Use of collagenase to facilitate guide wire crossing in total arterial occlusions
  • Use of collagenase to facilitate guide wire crossing in total arterial occlusions

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

In accordance with the present invention, an approach to significantly improve the procedural results of chronic occlusions is described. A method of local delivery of a therapeutic effective amount of a proteolytic enzyme-containing so formulation having a matrix-degrading enzyme, belonging to the family of matrix metalloproteinases, serine elastases, trypsin, neutral protease, chymotrypsin, aspartase, cysteinase and clostripain, can effectively alter the matrix content of the occluding plaque in a way that significantly facilitates guide wire crossing and substantially improves procedural success rates, without causing adverse effects of these enzymes on medial layers of the occluded artery and in adjacent non-occluded arterial segments.

Pathology of Chronic Total Occlusions in Human Coronary Arteries

The underlying atherosclerotic plaques in CTO are predominantly fibrocalcific39, consisting of smooth muscle cells, extracellular matrix and calcium and variable amounts of intrac...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Timeaaaaaaaaaa
Timeaaaaaaaaaa
Timeaaaaaaaaaa
Login to view more

Abstract

The use of a collagenase containing formulation for degrading collagen within an occlusive atherosclerotic plaque in a chronic fibrotic occlusion, chronically occluded animal tube or cavity. A medical-related apparatus is provided comprising a medical-related device having provided thereto a therapeutic amount of a collagen degrading composition comprising a proteiolytic enzyme containing formulation. A method is provided for treating chronically occluded animal tubes and cavities by administering a therapeutic effective amount of a proteolytic enzyme-containing formulation adjacent to an occluding atherosclerotic plaque, waiting for a pre-angioplasty waiting period, followed by crossing the plaque with an angioplasty guide wire.

Description

The present invention relates to the field of percutaneous interventions of occluded arteries using local infusion of collagenase or a combination of enzymes that include collagenase. BACKGROUND OF THE INVENTION Scope of Problem: Chronic total occlusions (CTO) are an extremely common finding in patients undergoing diagnostic catheterization. Up to 20% of patients undergoing angiography have been reported to have one or more chronic total coronary occlusions1. Balloon angioplasty is one treatment modality for CTO with the first successful report appearing in 19822. Percutaneous coronary interventions (PCI) continue to increase annually with >1 million procedures world-wide in 19983, and CTO currently account for approximately 10%-15% of PCI4-7. However, since PCI have severe limitations in this patient subset, clinicians frequently decide to refer these patients for bypass surgery or persist with (often ineffective) medical therapy. The presence of one or more CTO of vessels su...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61B17/12A01K67/027A61D1/00A61D7/00A61K38/46A61K38/48A61K38/51A61P7/02A61P9/10
CPCA61K38/4886A61K38/4833C12Y304/24003A61K2300/00A61P7/00A61P7/02A61P9/10
Inventor STRAUSS, BRADLEY H.
Owner STRAUSS BRADLEY H
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products